Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Gassó, P.
76  Ergebnisse:
Personensuche X
?
1

Early treatment with JNJ-46356479, a mGluR2 modulator, impr..:

Martínez-Pinteño, A. ; Rodríguez, N. ; Olivares, D....
Biomedicine & Pharmacotherapy.  158 (2023)  - p. 114079 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Effect of glutamate modulator jnj-46356479 and clozapine on..:

Martínez-Pinteño, A. ; Rodríguez, N. ; Olivares-Berjaga, D....
Neuroscience Applied.  2 (2023)  - p. 103563 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Associations between genetic risk scores and brain structur..:

Segura, A. Gonzalez ; Mezquida, G. ; Amoretti, S....
Neuroscience Applied.  2 (2023)  - p. 102635 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Genetic and environmental modulation of premorbid clinical ..:

Segura, A. Gonzalez ; De la Serna, E. ; Sugranyes, G....
Neuroscience Applied.  2 (2023)  - p. 101100 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Treatment with the positive allosteric modulator of the mgl..:

Berjaga, D. Olivares ; Pinteño, A. Martínez ; Rodríguez, N....
Neuroscience Applied.  2 (2023)  - p. 102521 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Neuroprotective effect of the positive allosteric modulator..:

Gassó, P. ; Martínez-Pinteño, A. ; Rodríguez, N....
Neuroscience Applied.  1 (2022)  - p. 100965 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Association between polygenic risk scores for psychiatric d..:

Rodríguez, N. ; Gassó, P. ; Blázquez, A....
Neuroscience Applied.  1 (2022)  - p. 100773 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Increased genetic risk and epigenetic age deacceleration in..:

Segura, A. Gonzalez ; Serna, E. de la ; Sugranyes, G....
Neuroscience Applied.  1 (2022)  - p. 100528 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Early treatment with positive allosteric modulator of mglu2..:

Martínez-Pinteño, A. ; Rodríguez, N. ; Olivares, D....
Neuroscience Applied.  1 (2022)  - p. 100954 , 2022
Link: https://doi.org/10.1016/..
 
?
10

A longitudinal study of gene expression in first-episode sc..:

Gassó, P. ; Rodríguez, N. ; Martínez-Pinteño, A....
Translational Psychiatry.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
11

P.0606 Identification of key genes involved in antipsychoti..:

Gassó, P. ; Martínez-Pinteño, A. ; Prohens, L....
European Neuropsychopharmacology.  53 (2021)  - p. S445 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Genetic associations of serotoninergic and GABAergic genes ..:

Garcia, A.E. Ortiz ; Boloc, D. ; Mas, S....
European Neuropsychopharmacology.  29 (2019)  - p. S509-S510 , 2019
Link: https://doi.org/10.1016/..
 
?
13

P.502 Epigenetic regulation of axon guidance as mediator bi..:

Garcia, M.L. Lazaro ; Blazquez Hinojosa, A. ; Boloc, D....
European Neuropsychopharmacology.  29 (2019)  - p. S353-S354 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Relationship between remission and recovery from a depressi..:

Hinojosa, A. Blazquez ; Gassó, P. ; Rodríguez, N....
European Neuropsychopharmacology.  29 (2019)  - p. S334-S335 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Personalized medicine begins with the phenotype: identifyin..:

Mas, S. ; Gassó, P. ; Rodríguez, N....
Acta Psychiatrica Scandinavica.  141 (2019)  6 - p. 541-552 , 2019
Link: https://doi.org/10.1111/..
 
1-15